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Abstract It has long been speculated that porcine cathelin is an 
N-terminal fragment of a longer precursor protein which 
possesses antimicrobial activity. In an attempt to find such a 
precursor, a cDNA clone was recently isolated and sequenced by 
screening a cDNA library from porcine bone marrow. In order to 
identify the functional activity of the putative protein encoded by 
an open reading frame, we have synthesized various lengths of 
peptides that correspond to the C-terminal region of the protein 
and examined them for their antimicrobial activities. We found 
that a 13 amino acid tryptophan-rich region with the sequence of 
VRRFPWWWPFLRR had strong antimicrobial activity with a 
wide spectrum. It showed potency against Escherichia coli, 
Pseudomonas eruginosa, Kiebsiella pneumonia, Staphylococcus 
epidermidis, Proteus mirabilis, and Streptococcus group D as 
well as Aspergillus fumigatus. The action of this peptide is 
bactericidal rather than bacteriostatic and this activity is 
completely inhibited by 2 mM MgC12. Our results indicate that 
the previously identified putative precursor encoded by the 
isolated cDNA indeed possesses a potent antimicrobial activity 
and that this 13 amino acid synthetic peptide is considered to be a 
potentially effective drug against various infections agents. 
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1. Introduction 
The recent findings of a variety of antimicrobial peptides in 
various organ systems had a significant impact on the under- 
standing of our immune system [1,2]. These peptides are 
widely distributed among living organisms and are considered 
to play crucial roles in the primary defense against intruding 
microorganisms. Although these peptides how a marked in- 
ter-species diversity in structure and spectrum of activity, the 
precursors of many antimicrobial peptides of porcine, bovine 
and rabbit origin contain a highly conserved preprotein region 
[3-5]. This region appears to be homologous to cathelin which 
is a putative proteinase inhibitor originally isolated from pig 
blood leukocytes. These peptides include Bac5 [6], indolicidin 
[7] and cyclic dodecapeptide from bovine [8] and CAP18 [9]. 
The mRNA sequences of these peptide share a remarkably 
high homology in signal peptide and pro sequence coding 
regions. However, they have only limited similarity in the 
region encoding the C-terminal regions. Therefore, it has 
been suggested that cathelin is the N-terminal fragment of a 
porcine homolog of antimicrobial peptides. 
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In an attempt o identify a precursor protein for cathelin 
and antimicrobial peptides, Pungercar et al. [10] recently 
screened the cDNA library from porcine bone marrow using 
a rabbit CAP18 cDNA as a probe and identified clones which 
encoded a potential precursor protein. An analysis of the nu- 
cleotide sequence of the cDNA revealed that it encoded a 228 
amino acid residue protein and that the N-terminal 98 residue 
is similar to cathelin [10]. On the other hand, the C-terminal 
half of 101 residues is very basic, rich in proline and arginine 
which appears to be very similar to cationic antimicrobial 
peptide such as bac5 and PR39 [11]. Therefore, they specu- 
lated that the C-terminal portion of this putative peptide may 
possess antimicrobial activity. In this report, we synthesized 
various peptides that corresponded to this region and tested 
them for their functional activities on both bacteria nd fungi. 
2. Materials and methods 
2.1. Peptide synthesis and bacterial and fungal strains 
The peptides were synthesized by Fmoc solid-phase synthesis using 
Opfp or Odhbt active esters on a Milligen 9050 peptide synthesizer 
(Perseptive Biosystems, Framingham, MA). The peptides were cleaved 
with phenollthiophenollanisolelTFA (1:1:2:30) for 1.5 h. Crude pep- 
tides were filtered, dried, solubilized in dilute acetic acid and lyopho- 
lized. The peptides were purified by preparative HPLC on a 20 × 200 
mm Vydac C18 column. Elution of the peptide (100 mg injected) was 
accomplished with a linear gradient from 0 to 80% acetonitrile con- 
taining 0.1% TGA over 30 min. Characterization was performed by 
electrospray mass spectrophotometry (Vestec, Houston TX). The 
homogeneity was confirmed to be more than 95% for all peptides. 
Pseudomonas eruginosa, Staphylococcus epidermidis, Klebsiella pneu- 
moniae, Proteus mirabilis, Group D Streptococcus and Candida albi- 
cans are all clinical isolates and identifications were carried out by the 
pathology department a Southern Illinois University. Eschelichia coli 
(DH5) and Aspergillus fumigatus trains are from our laboratory 
stock. 
2.2. Radial diffusion assay 
The radial diffusion assay was performed using double-layered 
agarose as described by Lehrer et al. [12] with minor modifications. 
Briefly, 2 × 10 ~ cells of mid-log phase bacteria grown in TSB medium 
were mixed with 1.0% agarose in 10 mM sodium phosphate buffer 
(pH 7.4) containing 0.02% Tween 20 and 0.03% Tryptic soy broth 
(TSB). The mixture was then poured into a petri dish. When the 
agarose was solidified, wells with a 2.5 mm diameter were made in 
the agarose and samples of the peptides in various concentrations 
were placed in each well. The plate was incubated at 37°C for 2 h. 
Top agar containing 1.0% agarose in 10 mM sodium phosphate buffer 
(pH 7.4) and 6% TSB was poured over it, and the plate was further 
incubated at 37°C for 18 h. The diameters of the inhibitory zones were 
measured for the quantitation of inhibitory activities. 
2.3. Bactericidal assay 
Bacterial cells were grown in TSB medium until the OD600 reached 
0.2. Cells were diluted with 10 mM sodium phosphate buffer (pH 7.2) 
and aliquots (2 × 105 cells) were mixed with various concentrations of 
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the peptides in 20 gl of sodium phosphate buffer. The mixtures were 
incubated at 37°C and samples were withdrawn at 10-rain intervals, 
diluted with sodium phosphate buffer, and plated on L-agar plates. 
After overnight incubation of the plates at 37°C, the number of col- 
onies was counted. 
2.4. MIC assay 
To determine the MIC, fungal strains were grown in YG media 
until the fungi reached the logarithmic phase. The cells diluted in 
YG medium [13] were placed in a 96-well plate along with a series 
of 2-fold dilution of the peptides, and then the plate was incubated at 
37°C for 24 h. MIC was defined as the lowest concentration at which 
there was no fungal growth. 
3. Results 
> 
100 
10 
3.1. Antibacterial activity of the tryptophan-rich peptides 
To synthesize and test the antimicrobial ctivity of the pro- 
line/arginine-rich peptide predicted from the cDNA sequence 
of porcine bone marrow, we performed hydrophobic moment 
analysis for the C-terminal region. The hydrophobic moment 
is a semi-empirical quantity based on computation and experi- 
mental measurements which describe the distribution of hy- 
drophilic and hydrophobic residue groups in a protein. There- 
fore, the hydrophobic moment indicates asymmetric regions 
of hydrophobicity or amphilicity [14]. Among several alpha- 
amphipathic regions, we chose the longest strech of an amino 
acid sequence which contained 13 amino acids including three 
tryptophans in a row. It should be noted that the three con- 
secutive tryptophans i  a very unique sequence and our data 
bank revealed that it is the rarest sequence among three con- 
secutive sequences of other amino acids. As shown in Table 1, 
peptide 1 with the sequence of VRRFPWWWPFLRR showed 
strong antibacterial effects on E. coli when tested by the radial 
diffusion assay. The result suggests that this 13 amino acid 
peptide is the functional domain of the predicted precursor 
protein which consists of 228 amino acid residues. We then 
synthesized several derivatives of this peptide, that were 
named peptides 2~ as shown in Table 1. Peptide 2, which 
consists of a 12 amino acid sequence corresponding to part of 
peptide 1 and two additional arginines at both ends, showed 
slightly higher activity than the original peptide 1. Peptide 3, 
which shared 9 amino acids with peptide 1, showed detectable 
but significantly less activity than peptide 1. On the other 
hand, peptide 4, which shared 7 amino acid residues with 
peptide 1, had no detectable activity. Therefore, the 13 amino 
acid residues of peptide 1 are considered to be a minimum 
sequence for antimicrobial ctivity. 
We have also tested the antimicrobial effects of the above 
peptides on other gram-positive and -negative bacteria in- 
cluding Pseudomonas, Klebsiella, Staphylococcus, Proteus 
and Streptococcus. As shown in Table 2, peptide 1 showed a 
broad range of antimicrobial ctivity on all organisms tested. 
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Fig. 1. Bactericidal ctivities of peptides. E coli cells grown to loga- 
rithmic phase were mixed with various concentrations of peptides, 
1 (X), 2 (A), 3 (+) and 4 (O) in phosphate buffer. After incubation 
at 37°C for 10 rain, aliquots of samples were withdrawn, diluted 
and plated on L-agar. The plates were incubated for 18 h and the 
number of colonies was counted. 
Again, peptide 2 showed slightly higher activity on those same 
bacteria, while peptide 3 showed low but detectable activity. 
However, peptide 4 showed no detectable activity on any 
organisms. 
3.2. Bactericidal activity of the peptide 
In order to examine whether the antimicrobial ctivities of 
the peptides are bacteriostatic or bactericidal, we performed a 
bactericidal assay for all peptides using E. coli. Cells were 
incubated with various concentrations of peptides in sodium 
phosphate buffer. After incubation for 10 min, the number of 
surviving cells was counted. As shown in Fig. 1, peptide I
showed strong bactericidal activity and 97% of cells were 
killed within 10 min at a concentration f 50 ~tg/ml. Peptide 
2 showed significantly ess bactericidal ctivity and peptides 3
and 4 showed minimum activity. These results uggest that the 
growth inhibitory effects of the peptides hown by the radial 
diffusion assay are due to bactericidal ctivities. However, it 
should be noted that the bactericidal ctivity of peptide 2 is 
significantly ess than that of peptide 1 while the antimicrobial 
activity of peptide 2, assayed by the radial diffusion method, 
was stronger than that of peptide 1. 
3.3. Antifungal activity of the peptide 
Because peptide 1 showed a broad spectrum of antimicro- 
bial activity, we also tested the effect of the peptide on two 
fungi, namely A. fumigatus and C. albicans. As shown in Ta- 
Table 1 
Zone inhibition assay for synthetic peptides 
Peptide no. Sequence Inhibitory activity ~at 
50 gg/well 5 gg/well 
Predicted from cDNA ...VRRFPWWWPFLRR... 
1 VRRFPWWWPFLRR 
2 RRRFPWVCWPFLRRR 
3 RFPWWWPFLR 
4 FPWWWPF 
I0 6 
11 7 
5 2 
0 0 
alnhibitory activities are expressed asdiameters of inhibited zones in mm. 
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Fig. 2. Effects of Ca 2+ and Mg 2+ on bactericidal activity. Bacterici- 
dal assay was performed as described in the text. E. coli ceils were 
mixed with peptide 1 (100 ~tg/ml) in the presence of indicated con- 
centrations of CaC12 (<>) and MgCI2 (t~). The mixture was incu- 
bated at 37°C for 10 min and surviving cells were counted as de- 
scribed in the legend to Fig. 1. 
ble 3, peptide 1 completely inhibited the growth of Aspergillus 
and Candida at concentrations of 250 and 1000 ~tg/ml, respec- 
tively. Peptide 2 also inhibited the growth of both fungal 
strains at similar concentrations. Peptides 3 and 4 also showed 
growth inhibitory effects on A. fumigatus at a concentration of
500 ~tg/ml but they had no inhibitory effect on C albicans. 
These results uggest that peptide 1 could be an effective anti- 
fungal drug though it required much higher concentrations 
than that for bacteria. 
3.4. Effects of  cation on the bactericidal activity 
We have investigated the effects of cations on the activity of 
peptide 1 since the activities of some antimicrobial peptides 
are known to be affected by cations [15]. E. coli cells were 
mixed with peptide 1 in the presence of various concentrations 
of MgC12 or CaCI2 and examined for their bactericidal ctiv- 
ities. As shown in Fig. 2, 15 mM CaC12 inhibited 80% of the 
antimicrobial activity. On the other hand, Mg 2+ showed a 
significantly greater inhibitory effect on the bactericidal ctiv- 
ity and only 2 mM MgC12 completely inhibited the activity of 
peptide 1. 
4. Discussion 
We have shown that the synthetic 13 amino acid peptide, 
wich corresponds to the C-terminal portion of a putative pre- 
cursor for antimicrobial proteins, indeed has strong antimi- 
crobial activities against various gram-positive and -negative 
bacteria and fungi. The original precursor protein predicted 
from the sequence of a cDNA clone consists of 228 amino 
acids, and the peptide with potential antimicrobial activity 
Table 2 
Zone inhibition assay with gram-positive and -negative bacteria 
97 
was speculated to reside within the 101 amino acid of the 
C-terminal [10]. We chose the longest stretch of amphipathic 
region among the 101 amino acid residues in an attempt o 
define the minimum sequence for the antimicrobial activity. 
This region of 13 amino acids contains three consecutive res- 
idues of tryptophan which is the least common sequence 
among the three consecutive identical amino acids found in 
Swisspro and PIR. Interestingly, Indolicidin which comprises 
13 amino acids also contains 5 tryptophan residues [7]. There- 
fore, these unique multiple tryptophan residues may indeed 
play an important role in antimicrobial activities. The addi- 
tion of two more arginine residues at both the N- and C- 
terminals to peptide 1 slightly increased the antimicrobial c- 
tivity while deletion of two arginine residues from peptide 1 
significantly reduced the activity. Therefore, consecutive argi- 
nine residues on both the N- and C-terminals of this peptide 
is considered to be an essential structure for the function. 
Because the native protein corresponding to the cDNA has 
not been isolated, we do not know whether the 13 amino acid 
peptide has full activity and, if so, what is the function of the 
remaining sequences. However, it is possible that this precur- 
sor protein could be further processed to be a smaller peptide 
which includes the 13 amino acids in order to show functional 
activity. Alternatively, these regions might possess ome other 
biological functions. 
Peptide 2, which has two additional arginine residues, 
showed stronger activity than peptide 1 using the zone inhibi- 
tion assay while it demonstrated lower activity using the bac- 
tericidal assay. This may be due to the difference between the 
two assay systems. The zone inhibition assay is dependent on 
the diffusion of the peptide in agar, while the bactericidal 
assay is not because it uses a liquid medium. The net charge 
of peptides 1 and 2 are calculated to be +4 and +6, respec- 
tively. Therefore, these additional arginines may make the 
peptide more diffusible, hence, it shows higher activity using 
the zone inhibition assay. 
Our results suggest hat Mg 2+ is a stronger inhibitor of the 
peptide than Ca 2+. The reason for the different effects of both 
ions is unknown at present. Mg 2+ may directly affect the 
activity by changing the conformation of the peptide or it 
may affect cellular factors that augment he killing effects of 
the peptide. In this context, it is worth noting that some 
autolytic enzymes are strongly inhibited by Mg 2+. Kim et 
al. [16] reported that a suicide enzyme called autolysin, which 
is involved in the autolysis of bacteria, is strongly inhibited by 
Mg 2+. Therefore, the action of peptide 1 may involve such 
cellular autolytic enzymes which are inhibited by cations. 
More recently, Vescovi et al. [17] reported that Mg 2+ is not 
merely a co-factor or a second messager, but that it directly 
activates a set of genes and that it functions as an external 
Inhibitory activity ~
Peptide 1 Peptide 2 Peptide 3 Peptide 4 
E. cob 5 
P. aeruginosa 3 
K. pneumoniae 7 
S. epidermidis 5 
P. mirabilis 1 
Streptococcus (Group D) 4 
5 2 0 
4 1 0 
7 2 0 
7 0 0 
2 0 0 
5 1 0 
alnhibitory activities are expressed as diameters of inhibited zones in mm. 
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Table 3 
MIC for Aspergillus fumigatus and Candida albicans 
Peptide no. MIC (lag/ml) 
A. fumigatus C. albicans 
1 250 1000 
2 250 1000 
3 500 > 1000 
4 500 > 1000 
signaling substrate. Therefore, it is tempting to assume that 
some of the gene products that are activated by cations act to 
protect bacterial cells from the killing effects of the antimicro- 
bial peptide. Although we need further analysis of the ion 
effects, our results would provide a useful tool for understand- 
ing the mechanism of action of the peptide. 
Our results indicate that peptide 1 has a wide spectrum of 
antimicrobial activity. The peptide is potent against both 
gram-positive and -negative bacteria as well as Aspergillus. 
This synthetic peptide is one of the shortest among all known 
antimicrobial peptides. Furthermore, it is easy to synthesize 
and quite soluble. Therefore, the peptide has potential as a 
therapeutic regent for a variety of infectious agents. Because 
this peptide contains three consecutive r sidues of tryptophan, 
we propose designating peptide 1 as Tritrpticin. 
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